Cochlear Americas
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $18.9M | 2,993 | 88.8% |
| Consulting Fee | $738,477 | 281 | 3.5% |
| Food and Beverage | $416,736 | 6,951 | 2.0% |
| Debt forgiveness | $403,205 | 259 | 1.9% |
| Travel and Lodging | $327,004 | 895 | 1.5% |
| Grant | $116,741 | 239 | 0.5% |
| Long term medical supply or device loan | $99,996 | 300 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95,898 | 54 | 0.5% |
| Charitable Contribution | $93,796 | 48 | 0.4% |
| Space rental or facility fees (teaching hospital only) | $85,763 | 55 | 0.4% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $2,250 | 2 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A post-approval, prospective, nonrandomized, single-arm multicenter investigation to evaluate the safety and effectiveness of cochlear implantation in children and adults with unilateral hearing loss/single-sided deafness | $2.8M | 0 | 254 |
| Cochlear Implant With Dexamethasone Eluting Electrode Array | $2.4M | 0 | 286 |
| Osia 2 System in a pediatric expansion study | $1.9M | 0 | 325 |
| Investigation of Advanced Speech Coding Strategies Using the Nucleus 24 Percutaneous Cochlear Implant | $1.0M | 0 | 132 |
| Preliminary Evaluation of a Dexamethasone Eluting Electrode Array | $768,323 | 0 | 17 |
| Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults | $718,650 | 16 | 629 |
| Nucleus Hybrid L24 Implant System New Enrollment Post Approval Study | $705,229 | 0 | 384 |
| A pivotal, prospective, open-label, multi-arm, multi-center non-randomized study of safety and effectiveness of cochlear implantation in an expanded population of adults with bilateral sensorineural hearing loss | $626,013 | 0 | 63 |
| Early Feasibility Study of Novel Tinnitus Implant System | $550,895 | 0 | 3 |
| Cochlear implantation during vestibular schwannoma removal or during labyrinthectomy surgery for the treatment of Menier's disease | $546,749 | 0 | 12 |
| Osia CPT code study | $516,591 | 0 | 54 |
| Post-Market Study on Clinical Efficacy of Osia 2 | $514,700 | 0 | 46 |
| Perimodiolar Implant Performance in Adults with Low-Frequency Residual Hearing | $488,227 | 0 | 153 |
| Observational quality improvement study | $300,000 | 0 | 2 |
| An early feasibility, prospective, exploratory study evaluating the performance of focused multipolar stimulation and sound coding enhancements with the Phoenix Research System in adult cochlear implant recipients (SASC) | $232,622 | 0 | 15 |
| Implant design | $170,851 | 0 | 15 |
| Insertion Microphonic Study | $168,458 | 0 | 8 |
| Cochlear implantation during acoustic neuroma tumor resection | $159,337 | 0 | 6 |
| The effect of neuromodulation on cochlear implant performance. | $146,972 | 0 | 2 |
| EAS Research | $129,966 | 0 | 9 |
| Emergence of EAS benefit in adult and pediatric CI users with acoustic hearing preservation | $127,195 | 0 | 6 |
| Complete Cochlear Implant Care (CCIC) Requiring a Single On-site Visit: A Prospective Pilot Study for Highlighy Coordinated Health Care | $126,430 | 0 | 2 |
| Complete Cochlear Implant Care (CCIC Requiring a Single On-Site Visit: A Prospective Pilot Study for Highly Coordinated Health Care) | $117,987 | 0 | 5 |
| A Clinical Trial Protocol to Determine the Effects of Cochlear Implantation on Cognitive Functioning in Older Adults | $106,506 | 0 | 1 |
| Impact of Intraoperative Electrocochleography (ECoG) Monitoring on Post-Operative Hearing Preservation | $105,466 | 0 | 11 |
| Clinic Investigation of New CI Delivery Models in a Nucleus CI Population | $90,102 | 0 | 59 |
| Randomized Controlled Trial of Immediate versus Delayed Cochlear Implantation | $85,002 | 0 | 29 |
| Adult Cochlear Implant Candidacy and Outcomes: A Retrospective Analysis | $81,773 | 0 | 40 |
| Encoding Temporal Fine Structure for Cochlear Implants | $72,690 | 0 | 1 |
| Investigation of the FAST Sound Coding Strategy in Newly Implanted Adult Cochlear Implant Recipients | $70,226 | 0 | 31 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Daniel Zeitler, M.d, M.D | Otology & Neurotology | Seattle, WA | $206,527 | $0 |
| Bruce Gantz, Md, MD | Otolaryngology | Iowa City, IA | $84,750 | $0 |
| David Kelsall, Md, MD | Otology & Neurotology | Englewood, CO | $83,708 | $0 |
| Dr. John Roland, M.d, M.D | Otology & Neurotology | New York, NY | $77,825 | $0 |
| Dr. Jacques Herzog, Md, MD | Specialist | Saint Louis, MO | $42,505 | $0 |
| Dr. Craig Buchman, Md, MD | Otolaryngology | Saint Louis, MO | $34,756 | $0 |
| Kevin Brown, Md, MD | Otolaryngology | Chapel Hill, NC | $29,436 | $0 |
| Anne Cosgriff, Md, MD | General Practice | Denver, CO | $26,938 | $0 |
| Courtney Voelker, M.d., P.h.d, M.D., P.H.D | Specialist | Los Angeles, CA | $26,416 | $0 |
| Dr. Eric Wilkinson, Md, MD | Otolaryngology | Meridian, ID | $25,510 | $0 |
| Peter Weber, Md, MD | Otolaryngology | Boston, MA | $24,725 | $0 |
| Dr. Sarah Mowry, Md, MD | Otolaryngology | Cleveland, OH | $22,194 | $0 |
| Michael Shinners, Md, MD | Otolaryngology | Fargo, ND | $19,108 | $0 |
| Matthew Carlson, Md, MD | Otolaryngology | Rochester, MN | $16,402 | $0 |
| Dr. Maura Cosetti, M.d, M.D | Otolaryngology | Shreveport, LA | $16,370 | $0 |
| Sean Mcmenomey, Md, MD | Otology & Neurotology | New York, NY | $15,008 | $0 |
| Dr. Varun Varadarajan, Md, MD | Otology & Neurotology | Sacramento, CA | $12,911 | $0 |
| Dr. Daniel Jethanamest, M.d, M.D | Otolaryngology | New York, NY | $11,793 | $0 |
| Jack Wazen, Md, MD | Otology & Neurotology | Sarasota, FL | $11,197 | $0 |
| Jacob Hunter, M.d, M.D | Otology & Neurotology | Philadelphia, PA | $11,196 | $0 |
| Akira Ishiyama, Md, MD | Otolaryngic Allergy | Los Angeles, CA | $11,134 | $0 |
| Dr. Seilesh Babu, Md, MD | Otolaryngology | Farmington Hills, MI | $10,865 | $0 |
| Marlan Hansen, Md, MD | Otology & Neurotology | Iowa City, IA | $10,770 | $0 |
| Dr. Alex Sweeney, M.d, M.D | Otolaryngology | Houston, TX | $10,738 | $0 |
| Dr. Si Chen, Md, MD | Otolaryngology | Gainesville, FL | $10,353 | $0 |
Top Products
- Nucleus $5.8M
- Cochlear $3.7M
Associated Products (11)
- Nucleus $6.2M
- Cochlear $3.7M
- COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE $3.7M
- OSIA OSI300 IMPLANT $700,262
- Cochlear Nucleus CI622 cochlear implant with Slim Straight electrode $522,900
- Osia $514,700
- Cochlear Osia OSI200 Implant $507,591
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode $336,052
- Cochlear Nucleus CI612 cochlear implant with Contour Advance electrode $213,417
- Cochlear Nucleus Hybrid L24 cochlear implant $50,011
- Cochlear Nucleus CI624 cochlear implant with Slim 20 electrode $47,320
Payment Categories
- Food & Beverage $416,736
- Consulting $738,477
- Travel & Lodging $327,004
- Research $18.9M
About Cochlear Americas
Cochlear Americas has made $21.2M in payments to 2,015 healthcare providers, recorded across 12,077 transactions in the CMS Open Payments database. In 2024, the company paid $2.5M. The top product by payment volume is Nucleus ($5.8M).
Payments were distributed across 82 medical specialties. The top specialty by payment amount is Otolaryngology ($644,917 to 1,069 doctors).
Payment categories include: Food & Beverage ($416,736), Consulting ($738,477), Research ($18.9M), Travel & Lodging ($327,004).
Cochlear Americas is associated with 11 products in the CMS Open Payments database, including Nucleus, Cochlear, and COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE.